Summary: Adoption and Workflow
- eRx w/ advanced transactional capabilities can be rapidly adopted by small, community-based practices
- PMS integration, no license fee + small incentive
- Large (>2/3) dependence on surrogates
- Implications for decision support and safety benefits unclear
- Policy guidance? P4P?
- Big impact on efficiency and communication channels, but...
- Paper-based internal communication still predominates
- Faxing is tough to beat re: overall resource requirements
- Opportunity for additional efficiency with more pharmacy participation plus true e-messaging within the practices
- Conventional wisdom challenged:
- eRenewals drive adoption (?)
- Surrogates provide bridge to MD adoption (?)
- eRx is a stepping stone to a full EMR (?)
Previous Slide Contents Next Slide ![Next Slide](https://webarchive.library.unt.edu/eot2008/20081105141558im_/http://www.ahrq.gov/images/arrow_rt.gif)